4Lynch BA, Lambeng N, Marchettic C, et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam [ J ]. Proo Natl Acad Sei, 2004, 101 (26): 9861-9866.
5Niespodziany I, Klitgaard H, Margineanu DG. Levetiracetam inhibits the high-voltage-activated Ca^2+ current in pyramidal near ones of rat hippocampal slices [ J ]. Neurosci Leet, 2001, 306 (1-2) : 5-8.
6Rigo JM, Hans G, Nguyen L, et al. The anti-epileptic drug levetiracetam reverses the inhibition by negative allosterie modulators of GABA-and glycine-gated currents [ J ]. BR J Phatmacol, 2002, 136(5) : 659-672.
7Loscher W, Honack D, Rlndfeldt C. Antiepilepto-genie effects of the novel anticonvulsant levetiraeetam in the kingling model of temporal lobe epilepsy [J]. J Pharnacol Exp Ther, 1998, 284(2) : 474-479.
8Carunchio J, Pieri M, Ciotti MT, et al. Modulation of AMPA receptors in cultured cortical neurons induced by the antiepileptic drug levetiracetam [ J ]. Epilepsia, 2007, 48 (4) : 654-662.
9Tong X, Patsalos PN. A mierodialysis study of the novel antiepileptie drug levetiracetam: extraceUular pharmaeokinefics and effect on taurine in rat brain [J]. Br J Pharmacol, 2001, 133 (6): 867-874.
10Glauser TA, Ayala R, Eherman RD, et al. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures [J]. Neurology, 2006, 66: 1654-1660.